about
1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition.M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts.Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activationTargeting the Microenvironment in High Grade Serous Ovarian Cancer
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting TGF-β Signaling for Therapeutic Gain.
@en
Targeting TGF-β Signaling for Therapeutic Gain.
@nl
type
label
Targeting TGF-β Signaling for Therapeutic Gain.
@en
Targeting TGF-β Signaling for Therapeutic Gain.
@nl
prefLabel
Targeting TGF-β Signaling for Therapeutic Gain.
@en
Targeting TGF-β Signaling for Therapeutic Gain.
@nl
P2860
P1476
Targeting TGF-β Signaling for Therapeutic Gain.
@en
P2093
Rosemary J Akhurst
P2860
P356
10.1101/CSHPERSPECT.A022301
P577
2017-02-28T00:00:00Z